Abstract
Several epidemiological studies have suggested that the incidence of male reproductive organ malformations, including hypospadias or cryptorchidism, has increased due to fetal-stage exposure to environmental pollutants. However, the association of chemical exposure with the expression of target regulatory genes in the tissues of patients has not yet been reported. Because experimental approaches or clinical trials in human studies are limited, especially those using fetal and/or infants, it is difficult to obtain clear physiological evidence of mechanisms underlying male reproductive malformations. Thus, the lack of physiological evidence makes this issue controversial. We analyzed preputial tissues from patients with hypospadias (n = 23) and phimosis (n = 16). The atypical CYP1 family genes, CYP1A1 and CYP1B1, are potential biomarkers of environmental chemical exposure. We then compared the expression levels of CYP1A1 and CYP1B1 between hypospadias and phimosis samples by quantitative RT-PCR analysis. The mRNA expression levels of SRD5A2 and AR also were measured, because the androgen-related genes involved in the onset of disorders of male reproductive system. A significantly higher CYP1B1 expression level and a lower AR expression level were observed in the hypospadias groups than in the phimosis group. Positive correlations (P < 0.001) between the mRNA expression levels of the CYP1 family and SRD5A2 were found in patients with hypospadias but not in those with phimosis. Moreover, the methylation levels of the four genes were determined by bisulfite genomic sequencing. Although the SRD5A2 promoter region showed moderate methylation, no methylation was detected in CYP1A1, CYP1B1, or AR. There was no significant difference in SRD5A2 promoter methylation level between hypospadias and phimosis patients. Negative correlations were found between the methylation level of SRD5A2, especially at the − 221 Sp1 site, and the CYP1 family mRNA expression levels (CYP1A1, p = 0.002; CYP1B1, p = 0.007) in hypospadias patients, but not in phimosis patients. The significant positive association of mRNA expression level and the negative association of methylation level of the SRD5A2 gene with the mRNA expression levels of CYP1 family genes in the preputial tissue seem to indicate the chemical exposure of patients with hypospadias.
Highlights
Participants and Sample PreparationJapanese patients with hypospadias (n = 23) and phimosis (n = 16) were studied
Laboratory of Environmental Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo‐ku, Tokyo 113‐0033, Japan
We examined the methylation level of the CpG islands of CYP1A1, CYP1B1, and androgen receptor (AR) genes; no methylation of these three genes was detected in all the samples examined
Summary
Japanese patients with hypospadias (n = 23) and phimosis (n = 16) were studied. Preputial skin samples (approximately 1 mm3) of patients were collected at the time of surgery after obtaining their informed consent. Total RNA and DNA were purified from frozen skin samples using ISOGEN (Nippongene, Tokyo, Japan). The protocol of quantitative real-time RT-PCR analysis was as described previously (Ohsako et al 2010). The target genes in the reverse-transcribed RNAs were amplified with SYBR Premix Ex Taq (Perfect Real Time) system (TaKaRa, Kusatus, Japan) using a LightCycler (Roche Manheim, Germany). The values were adjusted to cyclophilin-B (PPIB) level
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Archives of Environmental Contamination and Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.